Efficacy of the device in targeting tiotropium to the small airways in COPD

M. Biddiscombe (London, United Kingdom), A. Saleem (London, United Kingdom), S. Meah (London, United Kingdom), V. Mak (London, United Kingdom), O. Usmani (London, United Kingdom), A. Pellowe (Amanda.pellowe@yale.edu / Yale University,New Haven), J. Li (jia.li.jl2875@yale.edu / Shanghai Jiao Tong University,Shanghai), X. Peng (xueyan.peng@yale.edu / Yale University,New Haven), A. Gonzalez (Anjelica.gonzalez@yale.edu / Yale University,New Haven), E. Herzog (erica.herzog@yale.edu / Yale University,New Haven)

Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Session: Pulmonary drug delivery: inhaler use, devices and technologies
Session type: Thematic Poster
Number: 1017
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Biddiscombe (London, United Kingdom), A. Saleem (London, United Kingdom), S. Meah (London, United Kingdom), V. Mak (London, United Kingdom), O. Usmani (London, United Kingdom), A. Pellowe (Amanda.pellowe@yale.edu / Yale University,New Haven), J. Li (jia.li.jl2875@yale.edu / Shanghai Jiao Tong University,Shanghai), X. Peng (xueyan.peng@yale.edu / Yale University,New Haven), A. Gonzalez (Anjelica.gonzalez@yale.edu / Yale University,New Haven), E. Herzog (erica.herzog@yale.edu / Yale University,New Haven). Efficacy of the device in targeting tiotropium to the small airways in COPD. 1017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of tiotropium and indacaterol alone or the combination on dynamic lung hyperinflation and exercise tolerance in COPD
Source: International Congress 2014 – Asthma and COPD management
Year: 2014


Nebulized formoterol improves airway function in COPD subjects receiving maintenance tiotropium
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008

Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients
Source: Annual Congress 2010 - COPD: management
Year: 2010


Beclomethasone, formoterol and glycopyrronium: ceiling effect in small airways of COPD patients
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Year: 2020




Once-daily tiotropium Respimat add-on therapy improves lung function in children with moderate symptomatic asthma, independent of the degree of airflow obstruction
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017


Ciclesonide improves measures of small airway involvement in asthma
Source: Eur Respir J 2008; 31: 1213-1220
Year: 2008



Additional benefits of beclomethasone/formoterol extrafine combination treatment on small airways function in asthma
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009

Comparison of indacaterol with tiotropium or once-daily dual long-acting bronchodilator therapy with roflumilast for severe COPD
Source: International Congress 2014 – Markers
Year: 2014

Efficacy of combined budesonide/formoterol delivered via turbuhaler on lung function and asthma control in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 496s
Year: 2003

The combination therapy with inhaled tiotropium bromide and indacaterol in COPD improves the peripheral airway function in static and dynamic status
Source: International Congress 2014 – Asthma and COPD management
Year: 2014

Effect of inhaled tiotropium on tracheobronchial clearance in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 245s
Year: 2001

Comparison of spirometric efficacy of fluticasone/salmeterol plus tiotropium and tiotropium alone in moderate COPD
Source: Annual Congress 2009 - New bronchodilators
Year: 2009


Once-daily QVA149 improves lung function and dyspnoea compared with tiotropium plus formoterol: The QUANTIFY study
Source: International Congress 2014 – Asthma and COPD management
Year: 2014


Evaluation of airway sGaw in Japanese COPD patients treated with triple therapy using salmeterol/fluticasone propionate 50/250 and tiotropium bromide
Source: International Congress 2015 – COPD: interesting notes
Year: 2015


Bronchodilator efficacy of tiotropium in patients with mild COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 616s
Year: 2006

A comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a double-blind, efficacy and safety study in Chinese adults with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 213s
Year: 2006

Efficacy of tiotropium Respimat® in adults with moderate asthma, by baseline LTRA use
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


Once-daily tiotropium Respimat add-on therapy improves lung function and asthma control in moderate symptomatic asthma, independent of baseline characteristics
Source: International Congress 2017 – Clinical points to ponder in asthma
Year: 2017


The effects of extrafine beclomethasone/formoterol on hyperinflation and airway geometry in COPD patients
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012


Dual bronchodilation with once-daily QVA149 improves lung function and reduces exacerbations in patients with COPD: The IGNITE trials
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013